Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 4/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | CCR3 | P51677 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.46 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6312662 | 1.00 | EPHX1 (0.52) | EPHX1MEN1GAAHTTKMT2A | |
| Cyclohexane SCHEMBL5497140 | 0.86 | SIGMAR1 (0.46) | POLBCCR3ALDH1A1SIGMAR1SLC18A3 | |
| SCHEMBL6304074 | 0.86 | MEN1 (0.50) | EPHX1MEN1GAAHTTKMT2A | |
| SCHEMBL6304071 | 0.86 | MEN1 (0.50) | EPHX1MEN1GAAHTTKMT2A | |
| SCHEMBL6613640 | 0.85 | SIGMAR1 (0.47) | CCR3ALDH1A1SIGMAR1SLC18A3 | |
| SCHEMBL5497157 | 0.85 | CHRM2 (0.45) | CCR3SIGMAR1CHRM2 | |
| SCHEMBL6312646 | 0.84 | MEN1 (0.51) | EPHX1MEN1KMT2ACCR3ALDH1A1 | |
| SCHEMBL6312650 | 0.84 | MEN1 (0.51) | EPHX1MEN1KMT2ACCR3ALDH1A1 | |
| SCHEMBL6304033 | 0.84 | SIGMAR1 (0.58) | GAAPOLBCCR3ALDH1A1SMN1; SMN2 | |
| SCHEMBL6304036 | 0.84 | SIGMAR1 (0.58) | GAAPOLBCCR3ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1453804-B1 | CCR-3 RECEPTOR ANTAGONISTS VII | HOFFMANN LA ROCHE (CH) | 2007-08-22 | — | — | EP | claimed |
| US-7019007-B2 | CCR-3 receptor antagonists (I) | SYNTEX (U.S.A.) LLC (US) | 2006-03-28 | — | — | US | claimed |
| US-20030153578-A1 | CCR-3 receptor antagonists (I) | SYNTEX (U.S.A.) LLC | 2003-08-14 | — | — | US | claimed |
| EP-1453804-B1 | CCR-3 RECEPTOR ANTAGONISTS VII | HOFFMANN LA ROCHE (CH) | 2007-08-22 | — | — | EP | disclosed |
| EP-1453804-B1 | CCR-3 RECEPTOR ANTAGONISTS VII | HOFFMANN LA ROCHE (CH) | 2007-08-22 | — | — | EP | disclosed |
| US-7019007-B2 | CCR-3 receptor antagonists (I) | SYNTEX (U.S.A.) LLC (US) | 2006-03-28 | — | — | US | disclosed |
| US-6977265-B2 | Piperidine CCR-3 receptor antagonists | ROCHE PALO ALTO LLC (US) | 2005-12-20 | — | — | US | disclosed |
| EP-1453804-A2 | CCR-3 RECEPTOR ANTAGONISTS VII | F. Hoffmann-La Roche AG (CH) | 2004-09-08 | — | — | EP | disclosed |
| US-20030229121-A1 | Piperidine CCR-3 receptor antagonists | SYNTEX (U.S.A.) LLC | 2003-12-11 | — | — | US | disclosed |
| US-20030153578-A1 | CCR-3 receptor antagonists (I) | SYNTEX (U.S.A.) LLC | 2003-08-14 | — | — | US | disclosed |
| WO-2003045917-A2 | CCR-3 RECEPTOR ANTAGONISTS VII | F. HOFFMANN-LAROCHE AG (CH) | 2003-06-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030229121-A1 | Piperidine CCR-3 receptor antagonists | CCR1, CCR3, CCRL2 | EPHX1 1180/4885MEN1 4556/4885GAA 4327/4885 |
| US-20030153578-A1 | CCR-3 receptor antagonists (I) | CCR1, CCR3, CCR4 | EPHX1 1185/4885MEN1 4093/4885GAA 4591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.